a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children. JORNAY PM™ is the first and only evening-dosed methylphenidate product commercially available ...
For the longest time, it was assumed that 5-6% of kids had attention-deficit hyperactivity disorder (ADHD), but the rates are ...
The CDC reports that half of all adults with an ADHD diagnosis received the diagnosis in adulthood. "There is an increase in ...
For a long time it was assumed that somewhere between 5 and 6% of children have attention-deficit hyperactivity disorder (ADHD) ...
More grown-ups are admitting to having adult ADHD, calling attention to a disorder that affects about 2.58 per cent of the ...
About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...
Heston Blumenthal said he cannot watch award-winning television series The Bear because he fears it will be triggering after ...
Women and ADHD: Women with ADHD are more likely to exhibit inattentive symptoms such as daydreaming, trouble focusing, and ...
Pharmac has announced it'll fund new stimulant medicine lisdexamfetamine from December. The medicine -- branded as Vyvanse -- is taken once a day. Chief medical officer, David Hughes, says it's a ...
Attention-deficit/hyperactivity disorder can influence a child's weight in ways that will shape their long-term health, a new study says. The work is published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback